Fecal transplant to prevent infections in severe pancreatitis
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether a fecal microbiota transplant (FMT) can help prevent infections in people with moderately severe or severe acute pancreatitis. You may qualify if you are between 18 and 75, have had pancreatitis for 15 to 21 days, and already have a feeding tube in place.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old
- You have moderately severe or severe acute pancreatitis (with a CT score over 4)
- Your pancreatitis started 15 to 21 days ago
- You already have a nasojejunal (feeding) tube in place
- You have no active infections or conditions that would make the transplant unsafe
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a fecal transplant (transferring healthy gut bacteria from a donor) can help people with severe acute pancreatitis. It is for adults who are about 2 weeks past the onset of the disease and have started to recover but still have fluid buildup in the pancreas.
This trial tests whether taking a probiotic called Bifidobacterium longum can help people with acute pancreatitis recover better. The study compares the probiotic against a placebo (a pill with no active ingredient) to see if it reduces inflammation and complications.
This trial tests whether taking capsules with healthy donor bacteria (fecal transplant) can help people who have severe diarrhea after surgery to remove part or all of the pancreas. The treatment aims to restore gut balance and reduce diarrhea.
This study tests whether giving patients a special preparation of healthy donor stool (called fecal microbiota transplantation) can help with feeding intolerance, which is when the gut cannot handle food or nutrition given through a tube. If this works, it may improve nutrition and recovery for critically ill patients in the intensive care unit.
This trial studies whether fecal microbiota transplantation (FMT)—a medical procedure using stool from a screened donor to restore gut bacteria—can improve safety and outcomes for people with certain bowel, immune, and metabolic conditions. It may help if your symptoms are thought to be related to an unhealthy gut microbiome, though eligibility is broad and depends on specific safety factors.
This trial tests whether fecal microbiota transplantation (FMT) can safely and effectively treat mild to moderate ulcerative colitis over the long term. FMT involves transferring stool from a healthy donor to restore a healthy balance of gut bacteria.
Hear when a new Acute Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.